31 research outputs found
The course and effectiveness of combination antiviral therapy of HCV-infection with extrahepatic manifestations
In the coming years is projected to increase the number of patients with chronic HCV-infection. Increases in registration of extrahepatic manifestations of hepatitis Π‘ with proven involvement of agent as an etiologic factor. The study shows the clinical manifestations of lesions of the cardiovascular, nervous and urinary systems in HCV-infection. Displaying a more severe course of hepatitis Π‘ with extrahepatic manifestations. Marked decrease of sustained virological response in patients with extrahepatic manifestations, which allows us to consider them as an independent predictor of the effectiveness of combination antiviral therapy of HCV-infection.Π Π±Π»ΠΈΠΆΠ°ΠΉΡΠΈΠ΅ Π³ΠΎΠ΄Ρ ΠΏΡΠΎΠ³Π½ΠΎΠ·ΠΈΡΡΠ΅ΡΡΡ ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΠ΅ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π° Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ HCV-ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠ΅ΠΉ. ΠΠΎΠ·ΡΠ°ΡΡΠ°Π΅Ρ ΡΠ΅Π³ΠΈΡΡΡΠ°ΡΠΈΡ Π²Π½Π΅ΠΏΠ΅ΡΡΠ½ΠΎΡΠ½ΡΡ
ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΠΉ Π²ΠΈΡΡΡΠ½ΠΎΠ³ΠΎ Π³Π΅ΠΏΠ°ΡΠΈΡΠ° Π‘ Ρ Π΄ΠΎΠΊΠ°Π·Π°Π½Π½ΡΠΌ ΡΡΠ°ΡΡΠΈΠ΅ΠΌ Π²ΠΎΠ·Π±ΡΠ΄ΠΈΡΠ΅Π»Ρ, ΠΊΠ°ΠΊ ΡΡΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠ°ΠΊΡΠΎΡΠ°. Π ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΈ ΠΏΡΠΈΠ²Π΅Π΄Π΅Π½Ρ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΡ ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΡ ΡΠ΅ΡΠ΄Π΅ΡΠ½ΠΎ-ΡΠΎΡΡΠ΄ΠΈΡΡΠΎΠΉ, Π½Π΅ΡΠ²Π½ΠΎΠΉ, ΠΌΠΎΡΠ΅Π²ΡΠ΄Π΅Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌ ΠΏΡΠΈ HCV-ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ. ΠΠΎΠΊΠ°Π·Π°Π½ΠΎ Π±ΠΎΠ»Π΅Π΅ ΡΡΠΆΡΠ»ΠΎΠ΅ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ Π²ΠΈΡΡΡΠ½ΠΎΠ³ΠΎ Π³Π΅ΠΏΠ°ΡΠΈΡΠ° Π‘ Ρ Π²Π½Π΅ΠΏΠ΅ΡΡΠ½ΠΎΡΠ½ΡΠΌΠΈ ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΡΠΌΠΈ. ΠΡΠΌΠ΅ΡΠ°Π΅ΡΡΡ ΡΠΌΠ΅Π½ΡΡΠ΅Π½ΠΈΠ΅ ΡΡΡΠΎΠΉΡΠΈΠ²ΠΎΠ³ΠΎ Π²ΠΈΡΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΎΡΠ²Π΅ΡΠ° Π² Π³ΡΡΠΏΠΏΠ΅ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ Π²Π½Π΅ΠΏΠ΅ΡΡΠ½ΠΎΡΠ½ΡΠΌΠΈ ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΡΠΌΠΈ, ΡΡΠΎ ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ΅Ρ ΡΠ°ΡΡΠΌΠ°ΡΡΠΈΠ²Π°ΡΡ ΠΈΡ
ΠΊΠ°ΠΊ Π½Π΅Π·Π°Π²ΠΈΡΠΈΠΌΡΠΉ ΠΏΡΠ΅Π΄ΠΈΠΊΡΠΎΡ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΊΠΎΠΌΠ±ΠΈΠ½ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ ΠΏΡΠΎΡΠΈΠ²ΠΎΠ²ΠΈΡΡΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ HCV-ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ
The clinical, epidemiological and laboratory characteristics of acute viral hepatitis Π‘ whith users of introvenous drugs
Viral hepatitis Π‘ remains a global problem of modern health care. It accounts for up to 20% of acute hepatitis, 70% of chronic hepatitis, 40% of liver cirrhosis in the terminal stage, from 15-20 to 60-70% of cases of hepatocellular carcinoma. The virus of hepatitis Π‘ has the highest horiogen potential. The aggravating factors have the significantly influence on the pathogenesis and clinical manifestations of HCV - infection, such as: alcoholism, drug addiction, medicinal liver disease, HBV/HCV mixed-infection. The patients with HCV, using drugs, have a shorter incubation period, more pronounced cytolytic and cholestatic syndromes, which affects on the clinical course and prognosis. This dictates the necessity to study the flow characteristics of HCV in drug users.ΠΠΈΡΡΡΠ½ΡΠΉ Π³Π΅ΠΏΠ°ΡΠΈΡ Π‘ (ΠΠΠ‘) ΠΏΡΠΎΠ΄ΠΎΠ»ΠΆΠ°Π΅Ρ ΠΎΡΡΠ°Π²Π°ΡΡΡΡ Π³Π»ΠΎΠ±Π°Π»ΡΠ½ΠΎΠΉ ΠΏΡΠΎΠ±Π»Π΅ΠΌΠΎΠΉ ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΠ³ΠΎ Π·Π΄ΡΠ°Π²ΠΎΠΎΡ
ΡΠ°Π½Π΅Π½ΠΈΡ. ΠΠ° Π΅Π³ΠΎ Π΄ΠΎΠ»Ρ ΠΏΡΠΈΡ
ΠΎΠ΄ΠΈΡΡΡ Π΄ΠΎ 20 % ΠΎΡΡΡΡΡ
Π³Π΅ΠΏΠ°ΡΠΈΡΠΎΠ², 70% Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
Π³Π΅ΠΏΠ°ΡΠΈΡΠΎΠ², 40% ΡΠΈΡΡΠΎΠ·ΠΎΠ² ΠΏΠ΅ΡΠ΅Π½ΠΈ Π² ΡΠ΅ΡΠΌΠΈΠ½Π°Π»ΡΠ½ΠΎΠΉ ΡΡΠ°Π΄ΠΈΠΈ, ΠΎΡ 15-20 Π΄ΠΎ 60-70 % ΡΠ»ΡΡΠ°Π΅Π² Π³Π΅ΠΏΠ°ΡΠΎΡΠ΅Π»Π»ΡΠ»ΡΡΠ½ΠΎΠΉ ΠΊΠ°ΡΡΠΈΠ½ΠΎΠΌΡ. ΠΠΈΡΡΡ Π³Π΅ΠΏΠ°ΡΠΈΡΠ° Π‘ ΠΎΠ±Π»Π°Π΄Π°Π΅Ρ Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ Π²ΡΡΠΎΠΊΠΈΠΌ Ρ
ΡΠΎΠ½ΠΈΠΎΠ³Π΅Π½Π½ΡΠΌ ΠΏΠΎΡΠ΅Π½ΡΠΈΠ°Π»ΠΎΠΌ. ΠΠ° ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅Π· ΠΈ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΡΡ
HCV-ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ ΡΡΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠ΅ Π²Π»ΠΈΡΠ½ΠΈΠ΅ ΠΎΠΊΠ°Π·ΡΠ²Π°ΡΡ ΠΎΡΡΠ³ΠΎΡΠ°ΡΡΠΈΠ΅ ΡΠ°ΠΊΡΠΎΡΡ: Π°Π»ΠΊΠΎΠ³ΠΎΠ»ΠΈΠ·ΠΌ, Π½Π°ΡΠΊΠΎΠΌΠ°Π½ΠΈΡ, Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΠΎΠ΅ ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΠ΅ ΠΏΠ΅ΡΠ΅Π½ΠΈ, HBV/HCV ΠΌΠΈΠΊΡΡ-ΠΈΠ½ΡΠ΅ΠΊΡΠΈΡ. Π£ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΠΠ‘, ΡΠΏΠΎΡΡΠ΅Π±Π»ΡΡΡΠΈΡ
Π½Π°ΡΠΊΠΎΡΠΈΠΊΠΈ, ΠΎΡΠΌΠ΅ΡΠ°Π΅ΡΡΡ Π±ΠΎΠ»Π΅Π΅ ΠΊΠΎΡΠΎΡΠΊΠΈΠΉ ΠΈΠ½ΠΊΡΠ±Π°ΡΠΈΠΎΠ½Π½ΡΠΉ ΠΏΠ΅ΡΠΈΠΎΠ΄, Π±ΠΎΠ»Π΅Π΅ Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΡΠ΅ ΡΠΈΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΈΠΉ ΠΈ Ρ
ΠΎΠ»Π΅ΡΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΠΉ ΡΠΈΠ½Π΄ΡΠΎΠΌΡ, ΡΡΠΎ ΠΎΠΊΠ°Π·ΡΠ²Π°Π΅Ρ Π²Π»ΠΈΡΠ½ΠΈΠ΅ Π½ΠΈ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ ΠΈ ΠΏΡΠΎΠ³Π½ΠΎΠ· Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ. ΠΡΠΎ Π΄ΠΈΠΊΡΡΠ΅Ρ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎΡΡΡ ΠΈΠ·ΡΡΠ΅Π½ΠΈΡ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠ΅ΠΉ ΡΠ΅ΡΠ΅Π½ΠΈΡ ΠΠΠ‘ Ρ Π½Π°ΡΠΊΠΎΠΏΠΎΡΡΠ΅Π±ΠΈΡΠ΅Π»Π΅ΠΉ
Transcriptome analyses of the Giardia lamblia life cycle
Author Posting. Β© The Author(s), 2010. This is the author's version of the work. It is posted here by permission of Elsevier B.V. for personal use, not for redistribution. The definitive version was published in Molecular and Biochemical Parasitology 174 (2010): 62-65, doi:10.1016/j.molbiopara.2010.05.010.We quantified mRNA abundance from 10 stages in the Giardia lamblia life cycle in vitro using
Serial Analysis of Gene Expression (SAGE). 163 abundant transcripts were expressed
constitutively. 71 transcripts were upregulated specifically during excystation and 42 during
encystation. Nonetheless, the transcriptomes of cysts and trophozoites showed major
differences. SAGE detected co-expressed clusters of 284 transcripts differentially expressed in
cysts and excyzoites and 287 transcripts in vegetative trophozoites and encysting cells. All
clusters included known genes and pathways as well as proteins unique to Giardia or
diplomonads. SAGE analysis of the Giardia life cycle identified a number of kinases,
phosphatases, and DNA replication proteins involved in excystation and encystation, which
could be important for examining the roles of cell signaling in giardial differentiation. Overall,
these data pave the way for directed gene discovery and a better understanding of the biology
of Giardia lamblia.BJD, DSR, and FDG were supported by NIH grants AI42488, GM61896, DK35108, and
AI051687. DP and SGS were supported by grants from the Swedish Natural Science Research
Council, the Swedish Medical Research Council, and the Karolinska Institutet. AGM, SRB,
SPP, and MJC were supported by NIH grant AI51089 and by the Marine Biological Laboratoryβs
Program in Global Infectious Diseases, funded by the Ellison Medical Foundation
Analysis of patients with acute coronary syndrome without ST segment elevation at the prehospital stage
The aim of the study to analyze the clinical, anamnestic, objective parameters of patients with STEMI at the prehospital stage and the tactics of their management.Π¦Π΅Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ β ΠΏΡΠΎΠ°Π½Π°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°ΡΡ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠ΅, Π°Π½Π°ΠΌΠ½Π΅ΡΡΠΈΡΠ΅ΡΠΊΠΈΠ΅, ΠΎΠ±ΡΠ΅ΠΊΡΠΈΠ²Π½ΡΠ΅ ΠΏΠ°ΡΠ°ΠΌΠ΅ΡΡΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΠΠΠ‘ΠΠST Π½Π° Π΄ΠΎΠ³ΠΎΡΠΏΠΈΡΠ°Π»ΡΠ½ΠΎΠΌ ΡΡΠ°ΠΏΠ΅ ΠΈ ΡΠ°ΠΊΡΠΈΠΊΡ ΠΈΡ
Π²Π΅Π΄Π΅Π½ΠΈΡ
The relationship predictors of effectiveness of combined antiviral therapy of the syndrome of endogenous intoxication in the patients with chronic viral hepatitis Π‘
Predictors of the effectiveness of combined antiviral therapy of chronic hepatitis Π‘ vims believe: the genotype of the virus, the initial level of viremia, age, sex, race, body weight, the initial level of alanine aminotransferase activity, the severity of fibrosis of the liver, route of transmission, genetic polporphism of IL-28, syndrome of iron overload, duration of infection, adherence to treatment, scheme of therapy. The prevalence of chronic viral hepatitis Π‘ infection among young people on the one hand and the increase in frequency stable virologic response to therapy in adolescence on the other, dictate the need for an adequate approach to the treatment of these patients. Assessment of the level of endogenous intoxication in the period of treatment and further observation with chronic viral hepatitis Π‘ shows the failure of compensatory mechanisms detoxifying function of the liver, check-in and after the antiviral therapy.ΠΡΠ΅Π΄ΠΈΠΊΡΠΎΡΠ°ΠΌΠΈ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΊΠΎΠΌΠ±ΠΈΠ½ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ ΠΏΡΠΎΡΠΈΠ²ΠΎΠ²ΠΈΡΡΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π²ΠΈΡΡΡΠ½ΠΎΠ³ΠΎ Π³Π΅ΠΏΠ°ΡΠΈΡΠ° Π‘ ΡΡΠΈΡΠ°ΡΡ: Π³Π΅Π½ΠΎΡΠΈΠΏ Π²ΠΈΡΡΡΠ°, ΠΈΡΡ
ΠΎΠ΄Π½ΡΠΉ ΡΡΠΎΠ²Π΅Π½Ρ Π²ΠΈΡΡΡΠ΅ΠΌΠΈΠΈ, Π²ΠΎΠ·ΡΠ°ΡΡ, ΠΏΠΎΠ», ΡΠ°ΡΡ, ΠΌΠ°ΡΡΡ ΡΠ΅Π»Π°, ΠΈΡΡ
ΠΎΠ΄Π½ΡΠΉ ΡΡΠΎΠ²Π΅Π½Ρ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ Π°Π»Π°Π½ΠΈΠ½Π°ΠΌΠΈΠ½ΠΎΡΡΠ°Π½ΡΡΠ΅ΡΠ°Π·Ρ, Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΠΎΡΡΡ ΡΠΈΠ±ΡΠΎΠ·Π° ΠΏΠ΅ΡΠ΅Π½ΠΈ, ΠΏΡΡΡ ΠΏΠ΅ΡΠ΅Π΄Π°ΡΠΈ, Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΠΉ ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠΈΠ·ΠΌ Π³Π΅Π½Π° IL-28B, ΡΠΈΠ½Π΄ΡΠΎΠΌ ΠΏΠ΅ΡΠ΅Π³ΡΡΠ·ΠΊΠΈ ΠΆΠ΅Π»Π΅Π·ΠΎΠΌ, Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΡ ΠΈΠ½ΡΠΈΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ, ΠΏΡΠΈΠ²Π΅ΡΠΆΠ΅Π½Π½ΠΎΡΡΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ° ΠΊ Π»Π΅ΡΠ΅Π½ΠΈΡ, ΡΡ
Π΅ΠΌΠ° ΡΠ΅ΡΠ°ΠΏΠΈΠΈ. Π Π°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½ΠΈΠ΅ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π²ΠΈΡΡΡΠ½ΠΎΠ³ΠΎ Π³Π΅ΠΏΠ°ΡΠΈΡΠ° Π‘ ΡΡΠ΅Π΄ΠΈ ΠΌΠΎΠ»ΠΎΠ΄ΡΠΆΠΈ Ρ ΠΎΠ΄Π½ΠΎΠΉ ΡΡΠΎΡΠΎΠ½Ρ ΠΈ ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΠ΅ ΡΠ°ΡΡΠΎΡΡ ΡΡΠΎΠΉΠΊΠΎΠ³ΠΎ Π²ΠΈΡΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΎΡΠ²Π΅ΡΠ° Π½Π° ΡΠ΅ΡΠ°ΠΏΠΈΡ Π² ΡΠ½ΠΎΡΠ΅ΡΠΊΠΎΠΌ Π²ΠΎΠ·ΡΠ°ΡΡΠ΅ Ρ Π΄ΡΡΠ³ΠΎΠΉ, Π΄ΠΈΠΊΡΡΡΡ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎΡΡΡ Π°Π΄Π΅ΠΊΠ²Π°ΡΠ½ΠΎΠ³ΠΎ ΠΏΠΎΠ΄Ρ
ΠΎΠ΄Π° ΠΊ Π»Π΅ΡΠ΅Π½ΠΈΡ Π΄Π°Π½Π½ΠΎΠΉ Π³ΡΡΠΏΠΏΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ². ΠΡΠ΅Π½ΠΊΠ° ΡΡΠΎΠ²Π½Ρ ΡΠ½Π΄ΠΎΠ³Π΅Π½Π½ΠΎΠΉ ΠΈΠ½ΡΠΎΠΊΡΠΈΠΊΠ°ΡΠΈΠΈ Π² ΠΏΠ΅ΡΠΈΠΎΠ΄ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΈ Π΄Π°Π»ΡΠ½Π΅ΠΉΡΠ΅Π³ΠΎ Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΡ ΠΏΡΠΈ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΌ Π²ΠΈΡΡΡΠ½ΠΎΠΌ Π³Π΅ΠΏΠ°ΡΠΈΡΠ΅ Π‘ ΠΏΠΎΠΊΠ°Π·ΡΠ²Π°Π΅Ρ ΡΡΡΠ² ΠΊΠΎΠΌΠΏΠ΅Π½ΡΠ°ΡΠΎΡΠ½ΡΡ
ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΠΎΠ² Π΄Π΅Π·ΠΈΠ½ΡΠΎΠΊΡΠΈΠΊΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΉ ΡΡΠ½ΠΊΡΠΈΠΈ ΠΏΠ΅ΡΠ΅Π½ΠΈ, ΡΠ΅Π³ΠΈΡΡΡΠΈΡΡΠ΅ΠΌΠΎΠΌ ΠΈ ΠΏΠΎΡΠ»Π΅ ΠΏΡΠΎΠ²Π΅Π΄ΡΠ½Π½ΠΎΠΉ ΠΏΡΠΎΡΠΈΠ²ΠΎΠ²ΠΈΡΡΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ
Molecular Time-Course and the Metabolic Basis of Entry into Dauer in Caenorhabditis elegans
When Caenorhabditis elegans senses dauer pheromone (daumone), signaling inadequate growth conditions, it enters the dauer state, which is capable of long-term survival. However, the molecular pathway of dauer entry in C. elegans has remained elusive. To systematically monitor changes in gene expression in dauer paths, we used a DNA microarray containing 22,625 gene probes corresponding to 22,150 unique genes from C. elegans. We employed two different paths: direct exposure to daumone (Path 1) and normal growth media plus liquid culture (Path 2). Our data reveal that entry into dauer is accomplished through the multi-step process, which appears to be compartmentalized in time and according to metabolic flux. That is, a time-course of dauer entry in Path 1 shows that dauer larvae formation begins at post-embryonic stage S4 (48 h) and is complete at S6 (72 h). Our results also suggest the presence of a unique adaptive metabolic control mechanism that requires both stage-specific expression of specific genes and tight regulation of different modes of fuel metabolite utilization to sustain the energy balance in the context of prolonged survival under adverse growth conditions. It is apparent that worms entering dauer stage may rely heavily on carbohydrate-based energy reserves, whereas dauer larvae utilize fat or glyoxylate cycle-based energy sources. We created a comprehensive web-based dauer metabolic database for C. elegans (www.DauerDB.org) that makes it possible to search any gene and compare its relative expression at a specific stage, or evaluate overall patterns of gene expression in both paths. This database can be accessed by the research community and could be widely applicable to other related nematodes as a molecular atlas
Formation of Amyloid-Like Fibrils by Y-Box Binding Protein 1 (YB-1) Is Mediated by Its Cold Shock Domain and Modulated by Disordered Terminal Domains
YB-1, a multifunctional DNA- and RNA-binding nucleocytoplasmic protein, is involved in the majority of DNA- and mRNA-dependent events in the cell. It consists of three structurally different domains: its central cold shock domain has the structure of a Ξ²-barrel, while the flanking domains are predicted to be intrinsically disordered. Recently, we showed that YB-1 is capable of forming elongated fibrils under high ionic strength conditions. Here we report that it is the cold shock domain that is responsible for formation of YB-1 fibrils, while the terminal domains differentially modulate this process depending on salt conditions. We demonstrate that YB-1 fibrils have amyloid-like features, including affinity for specific dyes and a typical X-ray diffraction pattern, and that in contrast to most of amyloids, they disassemble under nearly physiological conditions
Integrative Analysis of the Caenorhabditis elegans Genome by the modENCODE Project
We systematically generated large-scale data sets to improve genome annotation for the nematode Caenorhabditis elegans, a key model organism. These data sets include transcriptome profiling across a developmental time course, genome-wide identification of transcription factor-binding sites, and maps of chromatin organization. From this, we created more complete and accurate gene models, including alternative splice forms and candidate noncoding RNAs. We constructed hierarchical networks of transcription factor-binding and microRNA interactions and discovered chromosomal locations bound by an unusually large number of transcription factors. Different patterns of chromatin composition and histone modification were revealed between chromosome arms and centers, with similarly prominent differences between autosomes and the X chromosome. Integrating data types, we built statistical models relating chromatin, transcription factor binding, and gene expression. Overall, our analyses ascribed putative functions to most of the conserved genome
STRUCTURAL ASPECTS OF INFLATIONARY PROCESSES
The article presents the structural analysis of the Russia inflation in 1992 β 2017 according to RosstatΒ with the focus on the latest phase of developmentΒ in terms of the economical sanctions. The inflation isΒ heterogeneous in itsΒ structure, because of the different degree of elementsβ coverage in theΒ economicalΒ system and because of the diverse role of each sector in theΒ reproduction process. Mechanisms and factors of pricing in various sectors of economy have individual features, and the price ratio between them varies according to changing power of inflation. In this content inflation can classified as systemic and local, balanced and unbalanced. The sector ofΒ inflation can be determined as drivers and outsiders of rising prices. In caseΒ of systemic inflation of the price process, structural parts of the systemΒ would be included. Balanced inflation occurs when the growth equality rates of the final products and rate of pricesβ growth would be presented. PriceΒ movement through phases of growth and decline forms a sector with minimum and maximum prices
The major mRNA-associated protein YB-1 is a potent 5β² cap-dependent mRNA stabilizer
mRNA silencing and storage play an important role in gene expression under diverse circumstances, such as throughout early metazoan development and in response to many types of environmental stress. Here we demonstrate that the major mRNA-associated protein YB-1, also termed p50, is a potent cap-dependent mRNA stabilizer. YB-1 addition or overexpression dramatically increases mRNA stability in vitro and in vivo, whereas YB-1 depletion results in accelerated mRNA decay. The cold shock domain of YB-1 is responsible for the mRNA stabilizing activity, and a blocked mRNA 5β²Β end is required for YB-1-mediated stabilization. Significantly, exogenously added YB-1 destabilizes the interaction of the cap binding protein, eIF4E, with the mRNA cap structure. Conversely, sequestration of eIF4E from the cap increases the association of endogenous YB-1 with mRNA at or near the cap, and significantly enhances mRNA stability. These data support a model whereby down-regulation of eIF4E activity or increasing the YB-1 mRNA binding activity or concentration in cells activates a general default pathway for mRNA stabilization